BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?

被引:0
|
作者
Guerrero-Ramos, F. [1 ,2 ,3 ]
机构
[1] Hosp Univ 12 Octubre, Serv Urol, Unidad Urooncol, Madrid, Spain
[2] ROC Clin, Madrid, Spain
[3] Hosp Univ HM Sanchinarro, Madrid, Spain
来源
ACTAS UROLOGICAS ESPANOLAS | 2023年 / 47卷 / 06期
关键词
BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; VALRUBICIN; FAILURE;
D O I
10.1016/j.acuro.2023.01.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:329 / 331
页数:3
相关论文
共 50 条
  • [1] Current advances in BCG-unresponsive non-muscle invasive bladder cancer
    Tse, Jennifer
    Singla, Nirmish
    Ghandour, Rashed
    Lotan, Yair
    Margulis, Vitaly
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (09) : 757 - 770
  • [2] Hyperthermic intravesical chemotherapy for BCG unresponsive or BCG ineligible non-muscle invasive bladder cancer
    de Jong, Joep J.
    Rosier, Marloes
    Boormans, Joost L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 613 - 613
  • [3] BCG-unresponsive non-muscle invasive bladder cancer: recommendations from the IBCG
    Kamat, Ashish M.
    Colombel, Marc
    Sundi, Debasish
    Lamm, Donald
    Boehle, Andreas
    Brausi, Maurizio
    Buckley, Roger
    Persad, Raj
    Palou, Joan
    Soloway, Mark
    Witjes, J. Alfred
    NATURE REVIEWS UROLOGY, 2017, 14 (04) : 244 - 255
  • [4] Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
    de Jong, Joep J.
    Hendricksen, Kees
    Rosier, Marloes
    Mostafid, Hugh
    Boormans, Joost L.
    BLADDER CANCER, 2018, 4 (04) : 395 - 401
  • [5] HYPERTHERMIC INTRAVESICAL CHEMOTHERAPY FOR BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    de Jong, Joep
    Hendricksen, Kees
    Rosier, Marloes
    Boormans, Joost
    Mostafid, Hugh
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1234 - E1235
  • [6] Developments in conservative treatment for BCG-unresponsive non-muscle invasive bladder cancer
    Dutto, Daniele
    Livoti, Simone
    Soria, Francesco
    Gontero, Paolo
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (10) : 1335 - 1348
  • [7] PHASE 3 RESULTS OF VICINIUM IN BCG-UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
    Shore, Neal
    O'Donnell, Michael
    Keane, Thomas
    Jewett, Michael A. S.
    Kulkarni, Girish S.
    Dickstein, Rian
    Wolk, Fred
    Dunshee, Curtis
    Belkoff, Laurence
    Dillon, Rachelle L.
    Cizeau, Jeannick
    Kassouf, Wassim
    JOURNAL OF UROLOGY, 2020, 203 : E72 - E72
  • [8] New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
    Asimakopoulos, Anastasios D.
    Kochergin, Maxim
    Colalillo, Gaia
    Fahmy, Omar
    Hassan, Fahmy
    Renninger, Markus
    Gallioli, Andrea
    Gavrilov, Pavel
    Gakis, Georgios
    BLADDER CANCER, 2023, 9 (03) : 237 - 251
  • [9] NON-MUSCLE INVASIVE BLADDER CANCER RESISTANT TO BCG
    Turker, Polat
    Turkeri, Levent
    ARCHIVOS ESPANOLES DE UROLOGIA, 2013, 66 (09): : 833 - 840
  • [10] Safety of Hyperthermic IntraVEsical Chemotherapy (HIVEC) for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
    Marquette, T.
    Walz, J.
    Rybikowski, S.
    Maubon, T.
    Branger, N.
    Fakhfakh, S.
    Verde, K. L.
    Dermeche, S.
    Gravis, G.
    Pignot, G.
    PROGRES EN UROLOGIE, 2020, 30 (01): : 35 - 40